T. Grabowski, Principes d'anatomie et de physiologie, DeBoëck Université Quebec, 1994.

B. Noble, N. Peet, H. Y. Stevens, A. Brabbs, J. R. Mosley et al., Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone, AJP: Cell Physiology, vol.284, issue.4, pp.934-943, 2003.
DOI : 10.1152/ajpcell.00234.2002

V. Everts, J. M. Delaisse, W. Korper, D. C. Jansen, W. Tigchelaar-gutter et al., The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation, Journal of Bone and Mineral Research, vol.13, issue.1, pp.77-90, 2002.
DOI : 10.1359/jbmr.2002.17.1.77

G. Tortora, S. Reynolds, and T. Grabowski, Principles of Anatomy and Physiology, Biological Sciences Textbooks, 2000.

D. Bailey, A. Martin, H. Mckay, S. Whiting, and R. Mirwald, Calcium Accretion in Girls and Boys During Puberty: A Longitudinal Analysis, Journal of Bone and Mineral Research, vol.10, issue.Suppl 8, pp.2245-50, 2000.
DOI : 10.1359/jbmr.2000.15.11.2245

H. Guénard, Physiologie humaine 3ème édition, Pradel, 2001.

J. Bonjour, T. Chevalley, S. Ferrari, and R. Rizzoli, The importance and relevance of peak bone mass in the prevalence of osteoporosis, Salud P??blica de M??xico, vol.51, issue.1, 2009.
DOI : 10.1590/S0036-36342009000700004

J. Bonjour, G. Theintz, F. Law, D. Slosman, and R. Rizzoli, Le pic de masse osseuse: r??alit??s et incertitudes, Archives de P??diatrie, vol.2, issue.5, pp.460-468, 1995.
DOI : 10.1016/0929-693X(96)81183-3

E. Seeman, Sexual Dimorphism in Skeletal Size, Density, and Strength, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.10, pp.4576-4584, 2001.
DOI : 10.1210/jcem.86.10.7960

J. A. Eisman, Genetics of Osteoporosis, Endocrine Reviews, vol.20, issue.6, pp.788-804, 1999.
DOI : 10.1210/edrv.20.6.0384

M. Peacock, C. Turner, M. Econs, and T. Foroud, Genetics of Osteoporosis, Endocrine Reviews, vol.23, issue.3, pp.303-326, 2002.
DOI : 10.1210/edrv.23.3.0464

B. Riggs, L. Melton, and R. Robb, A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and Men, Journal of Bone and Mineral Research, vol.14, issue.Suppl 1, pp.205-219, 2008.
DOI : 10.1359/jbmr.071020

E. Seeman, Pathogenesis of bone fragility in women and men, The Lancet, vol.359, issue.9320, pp.1841-50, 2002.
DOI : 10.1016/S0140-6736(02)08706-8

J. Stevens and E. Sogolow, Gender differences for non-fatal unintentional fall related injuries among older adults, Injury Prevention, vol.11, issue.2, pp.115-119, 2005.
DOI : 10.1136/ip.2004.005835

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1730193

A. Cotten, Imagerie musculosquelettique -Pathologies générales -Chap. 7 Ostéopathies Ed

J. Kanis, A. Oden, D. Laet, C. Mellstrom, and D. , Epidemiology of Osteoporosis and Fracture in Men, Calcified Tissue International, vol.75, issue.2, pp.90-99, 2004.
DOI : 10.1007/s00223-004-0287-6

C. Couris, P. Delmas, N. Burlet, and J. A. Kanis, Incidence des fractures ost??oporotiques majeures chez les fran??ais de plus de 50 ans, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.1, 2008.
DOI : 10.1016/j.respe.2008.02.031

L. Melton, I. Chrischilles, E. Cooper, and C. , How Many Women Have Osteoporosis?, Journal of Bone and Mineral Research, vol.70, issue.5, p.1005, 1992.
DOI : 10.1359/jbmr.2005.20.5.886

J. A. Kanîs, O. Johnell, A. Oden, D. Laet, C. Mellstrom et al., Epidemiology of Osteoporosis and Fracture in Men, Calcified Tissue International, vol.75, issue.2, pp.90-99, 2004.
DOI : 10.1007/s00223-004-0287-6

H. L. Blain, L'ost??oporose masculine: ??pid??miologie, physiopathologie, diagnostic, pr??vention et traitement, La Revue de M??decine Interne, vol.25, pp.552-559, 2004.
DOI : 10.1016/S0248-8663(04)80054-7

M. Maravic, L. Bihan, C. Landais, and P. , Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporosis International, vol.13, issue.12, pp.1475-80, 2005.
DOI : 10.1007/s00198-005-2031-0

S. Khosla, I. Melton, . Lj, R. Robb, J. Camp et al., Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Men, Journal of Bone and Mineral Research, vol.140, issue.5, pp.730-740, 2005.
DOI : 10.1359/JBMR.041228

H. Blain, A. Vuillemin, A. Blain, F. Guillemin, D. Talance et al., Age- Related Femoral Bone Loss in Men: Evidence for Hyperparathyroidism and Insulin-Like Growth Factor-1 Deficiency Journal of Gerontology: MEDICAL, pp.1285-1289, 2004.

E. Canalis, G. Mazziotti, A. Giustina, and J. Bilezikian, Glucocorticoid-induced osteoporosis: pathophysiology and therapy, Osteoporosis International, vol.89, issue.10, pp.1319-1328, 2007.
DOI : 10.1007/s00198-007-0394-0

K. Berris, A. Repp, and M. Kleerekoper, Glucocorticoid-induced osteoporosis, Current Opinion in Endocrinology, Diabetes and Obesity, vol.14, issue.6, pp.446-450, 2007.
DOI : 10.1097/MED.0b013e3282f15407

J. Compston, Guidelines for prevention and treatment of glucocorticoid-induced osteoporosis, Bone, vol.45, 2009.
DOI : 10.1016/j.bone.2009.07.039

M. Steinbuch, T. Youket, and S. Cohen, Oral glucocorticoid use is associated with an increased risk of fracture, Osteoporosis International, vol.15, issue.4, pp.323-331, 2004.
DOI : 10.1007/s00198-003-1548-3

J. Jackson and A. Spiekerman, Testosterone deficiency is common in men with hip fracture after a falls, Clin Res, vol.37, pp.131-137, 1989.

B. J. Kirath, S. S. Perkash, I. Tems, and M. , Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer, Urology, vol.57, issue.1, pp.127-159, 2001.
DOI : 10.1016/S0090-4295(00)00895-5

J. Bruder and M. Welsch, Prevalence of osteopenia and osteoporosis by central and peripheral bone minerai density m men with prostate cancer during androgen deprivation

G. Cizza, S. Primma, and G. Csako, Depression as a risk factor for osteoporosis, Trends in Endocrinology & Metabolism, vol.20, issue.8, 2009.
DOI : 10.1016/j.tem.2009.05.003

D. Goltzman and S. Morin, La relation entre la dépression et la perte osseuse. Le Point sur l'ostéoporose, 2009.

Y. Yang, J. Lewis, S. Epstein, and D. Metz, Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA, vol.296, issue.24, pp.2947-53, 2006.
DOI : 10.1001/jama.296.24.2947

L. Targownik, L. Lix, C. Metge, H. Prior, S. Leung et al., Use of proton pump inhibitors and risk of osteoporosis-related fractures, CMAJ Aug, vol.12, issue.1794, pp.319-345, 2008.

L. Targownik, L. Lix, S. Leung, and W. Leslie, Proton Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Minerai Density Loss, Gastroenterology, 2009.

J. Gavaler, V. Thiel, and D. , The Association between Moderate Alcoholic Beverage Consumption and Serum Estradiol and Testosterone Levels in Normal Postmenopausal Women: Relationship to the Literature, Alcoholism: Clinical and Experimental Research, vol.316, issue.1, p.87, 1992.
DOI : 10.1016/0002-8703(83)90492-1

K. Chung, Effects of chronic ethanol intake on aromatization of androgens and concentration of estrogen and androgen receptors in rat liver, Toxicology, vol.62, issue.3, pp.285-295, 0990.
DOI : 10.1016/0300-483X(90)90052-I

T. Holbrook and E. Barrett-connor, A prospective study of alcohol consumption and bone mineral density., BMJ, vol.306, issue.6891, pp.1506-1509, 1993.
DOI : 10.1136/bmj.306.6891.1506

S. Hoidrup, M. Gronbaek, A. Gttschau, and M. Schroll, Alcohol Intake, Beverage Preference, and Risk of Hip Fracture in Men and Women, American Journal of Epidemiology, vol.149, issue.11, pp.993-1001, 1999.
DOI : 10.1093/oxfordjournals.aje.a009760

R. Turner, Skeletal Response to Alcohol, Alcoholism: Clinical and Experimental Research, vol.23, issue.11, pp.1693-701, 2000.
DOI : 10.1016/0167-4889(86)90100-X

N. Binkley, P. Schmeer, P. Wasnich, R. Lenchik, and L. , What Are the Criteria by Which a Densitometric Diagnosis of Osteoporosis Can Be Made in Males and Non-Caucasians?, Journal of Clinical Densitometry, vol.5, issue.3, pp.9-27, 2002.
DOI : 10.1385/JCD:5:3S:S19

S. Cummings, P. Cawthon, K. Ensrud, J. Cauley, H. Fink et al., BMD and Risk ofHip and Nonvertebral Fractures in Older Men: A Prospective Study and Comparison With Older Women, Journal ofBone and Mineral Research, vol.21, issue.10, 2006.

P. Gamero, M. Ferreras, M. Karsdal, R. Nicamhlaoibh, and J. Risteli, Borel 0, et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways ofbone collagen degradation, J Bone Miner Res, vol.18, pp.859-67, 2003.

M. Saito, K. Marumo, K. Fujii, and N. Ishioka, Single-Column High-Performance Liquid Chromatographic???Fluorescence Detection of Immature, Mature, and Senescent Cross-Links of Collagen, Analytical Biochemistry, vol.253, issue.1, pp.26-32, 1997.
DOI : 10.1006/abio.1997.2350

G. Hein, C. Weiss, G. Lehmann, T. Niwa, G. Stein et al., Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings, Annals of the Rheumatic Diseases, vol.65, issue.1, pp.101-105, 2006.
DOI : 10.1136/ard.2004.034348

G. Hein, R. Wiegand, G. Lehman, G. Stein, and S. Franke, Advanced glycation end-products pentosidine and N??-carboxymethyllysine are elevated in serum of patients with osteoporosis, Rheumatology, vol.42, issue.10, pp.1242-1248, 2003.
DOI : 10.1093/rheumatology/keg324

M. Saito, L. Fujii, S. Soshi, and T. Tanaka, Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture, Osteoporosis International, vol.40, issue.Suppl, pp.986-95, 2006.
DOI : 10.1007/s00198-006-0087-0

X. Wang, X. Shen, X. Li, and C. Agrawal, Age-related changes in the collagen network and toughness of bone, Bone, vol.31, issue.1, pp.1-7, 2002.
DOI : 10.1016/S8756-3282(01)00697-4

P. Gamero, A. Schott, P. Meunier, and G. Chevrel, Impaired type I collagen C-telopeptide isomerization in patients with osteogenesis imperfecta, J Bone Miner Res, vol.21, p.429, 2006.

S. Viguet-carrin, P. Gamero, and D. , The role of collagen in bone strength, Osteoporosis International, vol.17, issue.3, pp.319-336, 2006.
DOI : 10.1007/s00198-005-2035-9

M. Saito and K. Marumo, Collagen cross-links as a determinant ofbone quality; a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus, Osteoporos Int. Review, 2009.

T. Bagwell, M. Banks, D. Butz, and S. Hausman-cohen, Risk factor assessment for osteoporosis and/or increased fracture risk in men. National Guideline Clearinghouse, 2008.

F. Richy, E. Schacht, M. Bruyere-0-gourlay, J. Reginster, H. Bischoff-ferrari et al., Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis Effect ofvitamin Don falls: a meta-analysis, CalcifTissue Int JAMA, vol.76291, issue.73, pp.176-1861999, 2004.

M. Visekruna, D. Wilson, and F. Mckiernan, Severely Suppressed Bone Turnover and Atypical Skeletal Fragility, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.8, pp.932948-2952, 2008.
DOI : 10.1210/jc.2007-2803

J. Desmeules, J. Biollaz, P. Bonnabry, and T. Buclin, Bisphosphonates au long cours: sécurité remise en question? Pharma-Flash, 2009.

. Bilezikian, The use of parathyroid hormone in the treatment of osteoporosis, Rev Endocr Metab Disord, vol.7, pp.113-121, 2006.

A. M. Kenny, K. M. Prestwood, K. M. Marcello, and L. G. , Raisz Determinants ofBone Density in Healthy Older Men With Low Testosterone Levels Journal ofGerontology: MEDICAL SCIENCES, pp.492-497, 2000.

E. Orwoll, L. Bevan, and K. Phipps, Determinants of Bone Mineral Density in Older Men, Osteoporosis International, vol.11, issue.10, pp.815-836, 2000.
DOI : 10.1007/s001980070039

P. Snyder, H. Peachey, P. Hannoush, J. Berline, L. Loh et al., Effect of Testosterone Treatment on Bone Mineral Density in Men Over 65 Years of Age, Journal of Clinical Endocrinology & Metabolism, vol.84, issue.6, pp.1966-1972, 1999.
DOI : 10.1210/jc.84.6.1966

P. Snyder, H. Peachey, P. Hannoush, and J. Berlin, Effect of testosterone treatment on bone minerai density in men over 65 years of age, J Clin Endocrinol Metab, vol.84, pp.1966-1972, 1999.

A. Falahati-nini, B. Riggs, E. Atkinson, O. Fallon, W. Eastell et al., Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men, Journal of Clinical Investigation, vol.106, issue.12, pp.1553-1560, 2000.
DOI : 10.1172/JCI10942

S. Khosla, E. Atkinson, C. Dunstan, O. Fallon, and W. , Author's Response: Effect of Estrogen Versus Testosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men, Journal of Clinical Endocrinology & Metabolism, vol.87, issue.8, pp.1550-1554, 2002.
DOI : 10.1210/jc.87.8.4009-a

C. Carani, K. Qin, M. Simoni, M. Faustini-fustini, S. Serpente et al., Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency, New England Journal of Medicine, vol.337, issue.2, pp.91-95, 1997.
DOI : 10.1056/NEJM199707103370204

R. Bouillon, M. Bex, D. Vanderschueren, and S. Boonen, Estrogens Are Essential for Male Pubertal Periosteal Bone Expansion, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.12, pp.6025-6029, 2004.
DOI : 10.1210/jc.2004-0602

L. Maffei, Y. Murata, V. Rochira, G. Tubert, C. Aranda et al., Dysmetabolic Syndrome in a Man with a Novel Mutation of the Aromatase Gene: Effects of Testosterone, Alendronate, and Estradiol Treatment, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.1, pp.61-70, 2004.
DOI : 10.1210/jc.2003-030313

V. Rochira, M. Faustini-fustini, A. Balestrieri, and C. Carani, Estrogen Replacement Therapy in a Man with Congenital Aromatase Deficiency: Effects of Different Doses of Transdermal Estradiol on Bone Mineral Density and Hormonal Parameters, The Journal of Clinical Endocrinology & Metabolism, vol.85, issue.5, pp.1841-1845, 2000.
DOI : 10.1210/jcem.85.5.6583

J. Bilezikian, A. Morishima, J. Bell, and M. Grumbach, Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency, New England Journal of Medicine, vol.339, issue.9, pp.599-603, 1998.
DOI : 10.1056/NEJM199808273390905

K. Hirotaka and K. Hiroshi, Androgen function on skeletal tissues: analysis of androgen receptor-deficient mice, Clinical calcium, vol.16, issue.3, pp.455-60, 2006.

K. Hirotaka, K. Hiroshi, and K. Shigeaki, Bone metabolism in androgen receptor-deficient mice, Clinical calcium, vol.13, issue.11, pp.1443-1448, 2003.

B. Ongphiphadhanakul, S. Thamprajamchit, S. Chanprasertyothin, L. Chailurkit, and R. Rajatanavin, Effect of estrogen replacement on insulin sensitivity, serum lipid and bone resorption marker in hypogonadal males, Maturitas, vol.42, issue.1, pp.85-89, 2002.
DOI : 10.1016/S0378-5122(02)00026-9

P. M. Doran, B. L. Riggs, E. J. Atkinson, and S. Khosla, Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men, Journal of Bone and Mineral Research, vol.15, issue.11, pp.2118-2125, 2001.
DOI : 10.1359/jbmr.2001.16.11.2118

J. Kearbey, W. Gao, R. Narayanan, S. Fisher, D. Wu et al., Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomizeù rats. Pharmaceutical Research(1H)-ones as novel selective androgen receptor modulators, Feb J Med Chem, vol.24, issue.50, pp.328-363, 2007.

P. Miller, Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial, Bone, vol.43, issue.2, pp.222-231, 2008.
DOI : 10.1016/j.bone.2008.04.007

J. Brown, Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*, Journal of Bone and Mineral Research, vol.24, issue.1, pp.153-61, 2009.
DOI : 10.1359/JBMR.040305

. Tammela, Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer The new englandjournal of medecine 361, 2009.

S. Khosla, Increasing Options for the Treatment of Osteoporosis, New England Journal of Medicine, vol.361, issue.8
DOI : 10.1056/NEJMe0905480

H. Bone, M. Clung, M. Roux, C. Recker, R. Eisman et al., Odanacatib, a Cathepsin-K inhibitor for Osteoporosis: A two year study, J Bone Miner Res, 2009.

G. Karsenty, Traiter l'ostéoporose en inhibant la sérotonine intestinale, Le Quotidien du Médecin N°8703, 2010.

E. Orwoll, M. Ettinger, S. Weiss, P. Miller, D. Kendler et al., Alendronate for the Treatment of Osteoporosis in Men, New England Journal of Medicine, vol.343, issue.9, pp.604-610, 2000.
DOI : 10.1056/NEJM200008313430902

J. Ringe, H. Faber, P. Farahmand, and A. Dorst, Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study, Rheumatology International, vol.11, issue.1, pp.427-431, 2006.
DOI : 10.1007/s00296-005-0004-4

E. Orwoll, W. Scheele, S. Paul, S. Adami, U. Syversen et al., The Effect of Teriparatide [Human Parathyroid Hormone (1-34)] Therapy on Bone Density in Men With Osteoporosis, Journal of Bone and Mineral Research, vol.104, issue.Suppl, pp.9-17, 2003.
DOI : 10.1359/jbmr.2003.18.1.9

J. Schousboe, B. Taylor, H. Fink, R. Kane, E. Orwoll et al., Cost-effectiveness of Bone Densitometry Followed by Treatment of Osteoporosis in Older Men, JAMA, vol.298, issue.6, 2007.
DOI : 10.1001/jama.298.6.629

J. Compsto:-?, Management of glucocorticoid-induced osteoporosis, Nat. Rev. Rheumatol, 2010.

F. Mette, J. Hitz, . Jensen, C. Peter, and . Eskildsen, Bone minera! density and bone markers in patients with a recent low-energy fracture: effect of 1 y of treatment with calcium and vitamin D, Am J Clin Nutr, vol.86, pp.251-260, 2007.

B. Tang, G. Eslick, and C. Nowson, Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis, The Lancet, vol.370, issue.9588, pp.657-66, 2007.
DOI : 10.1016/S0140-6736(07)61342-7

R. Vieth, P. Chan, and G. Macfarlane, Effi cacy and safety ofvitamin D3 intake exceeding the lowest observed adverse effect level, Am J Clin Nutr, vol.73, pp.288-94, 2001.

D. Laet, C. Kanis, J. Oden, A. Johanson, and H. , Body mass index as a predictor of fracture risk: A meta-analysis, Osteoporosis International, vol.14, issue.11, pp.1330-1338, 2005.
DOI : 10.1007/s00198-005-1863-y

E. Kurland, S. Heller, and B. Diamond, The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1?34)], Osteoporosis International, vol.18, issue.12, pp.992-999, 2004.
DOI : 10.1007/s00198-004-1636-z

J. Finkelstein, A. Hayes, J. Hunzelman, J. Wyland, H. Lee et al., The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis, New England Journal of Medicine, vol.349, issue.13, pp.1216-1226, 2003.
DOI : 10.1056/NEJMoa035725

K. G. Saag, Teriparatide or alendronate in glucocorticoid-induced osteoporosis, N

E. Seeman, J. Bilezekian, C. Cooper, and J. Kanis, Invest in your bones: Osteoporosis in Men, 2004.

E. Ostéoporoses-2ème, Groupe de recherche et d'information sur les ostéoporoses

M. Yamaguchi, Role of nutritional zinc in the prevention of osteoporosis, Molecular and Cellular Biochemistry, vol.50, issue.Suppl 2, 2009.
DOI : 10.1007/s11010-009-0358-0

A. Rodondi, P. Ammann, S. Ghilardi-beuret, and R. Rizzoli, Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly, J Nutr Health Aging, 2009.

M. Schûrch, R. Rizzoli, D. Slosman, and J. Bonjour, Protein supplements increase serum IGF-1 and decrease proximal femur bone loss in patients with a recent hip fracture, pp.327-329, 1996.

B. A. Briesacher, S. E. Andrade, H. Fouayzi, and K. A. Chan, Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions, Pharmacotherapy, vol.36, issue.4, pp.437-443, 2008.
DOI : 10.1097/00005650-199909000-00002

Y. Rolland and B. Vellas, La sarcopénie. La Revue de médecine interne, pp.150-160, 2009.

B. Jean-claude, Prévention de l'ostéoporose, diététique et activités physiques, 2005.

E. Gaffney-stomberg, K. L. Insogna, N. R. Rodriguez, J. E. Kerstetter-nelson, M. Rejeski et al., Increasing Dietary Protein Requirements in Elderly People for Optimal Muscle and Bone Health, Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association, pp.1073-1079, 2007.
DOI : 10.1111/j.1532-5415.2009.02285.x

G. Meyer, A. Wamke, R. Bender, and I. Mühlhauser, Effect on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial, BMJ, vol.326, issue.7380, p.76, 2003.
DOI : 10.1136/bmj.326.7380.76

N. Van-schoor, J. Smit, J. Twisk, L. Bouter, and P. Lips, Prevention of Hip Fractures by External Hip Protectors, JAMA, vol.289, issue.15, pp.1957-62, 2003.
DOI : 10.1001/jama.289.15.1957

P. Kothawala, E. Badamgarav, S. Ryu, R. Miller, and R. Halbert, Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for Osteoporosis, Mayo Clinic Proceedings, vol.82, issue.12, pp.1493-1501, 2007.
DOI : 10.1016/S0025-6196(11)61093-8

P. Fardellone, Int??r??t et limites des traitements antiost??oporotiques, EMC - Trait?? de m??decine AKOS, vol.2, issue.3, 2007.
DOI : 10.1016/S1634-6939(07)39648-8

C. Alexandre, C. Baudoin, G. Bréart, and P. Delmas, Ost??oporose, p.3, 2010.
DOI : 10.1016/B978-2-294-70633-2.50513-8

M. Lafage-proust, Le tissu osseux. [En ligne] Disponible sur, p.1603, 2010.

J. Bonjour, Comment le régime alimentaire, le mode de vie et la génétique influent sur le développement des os chez les jeunes, Belgian Bone Club. [en ligne] Disponible sur

B. Claude, B. Gérard, C. Thierry, D. Pierre, T. Monique et al., Ostéoporose : stratégies de prévention et de traitement Institut national de la santé et de la recherche médicale 1996 -INSERM. [en ligne] Disponible sur http, pp.1377-1603, 2010.

C. Roux, P. Orcel, and M. Audran, Fondation pour la Recherche Médicale Rencontre santé Août, 2005.

. Ministère-de-la-santé,-de-la-famille-et-des-personnes-handicapées, Projet de loi sur la politique de santé publique -Rapport d'objectifs de santé publique. [en ligne] Disponible sur : www.sante.gouv.fr/htm, p.3, 2010.

. Disponible-sur, has-sante.fr/portail, p.1603, 2010.

O. Frax and . Outil-d, Evaluation des Risques de Fractures Centre de Collaboration de !'Organisation Mondiale de la Santé pour les Maladies Métaboliques des Os Royaume-Uni. [en ligne] Disponible sur: http://www.shef.ac.uk/FRAX/tool FR.jsp?locationValue=12 76

. Ketterthill, [en ligne] Disponible sur : www .ketterthill.lu/fileadrnin/media/newsletter/ osteoporoselow. pdf 109, HAS. Aclasta, vol.1, pp.798074-1603, 2009.

V. Breuil, R. Chapurlat, F. Lévy-weil, and . Ostéoporose, [en ligne] Disponible sur: www.annee-rhumato.com 124 Assemblée nationale. Réforme de l'hôpital, texte 11°1210, amendement n° 395 Reet. 6 février, Disponible sur, p.3, 2007.

C. Santé, Santé des aînés. [en ligne] Disponible sur: http://sante.canoe.com/channel section details.asp?text id=1544&channel id=32&relation i d=3616, p.1603, 2010.

C. Wegelin, Ligue suisse contre le rhumatisme. [en ligne] Disponible sur: www.chiro-sante.ch/conseils.htm